Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    11287973 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Glivec in Ph Positive Lymphoblastic Leukemia
Conditions: Acute Lymphoblastic Leukemia;   Cromosome Philadelphia Positive
Interventions: Drug: chemotherapy;   Drug: Glivec
2 Unknown  Comparing Imatinib Standard Dose With Imatinib High Dose Induction in Pretreated Chronic Myeloid Leukemia (CML) Patients in Chronic Phase
Condition: Chronic Myeloid Leukemia
Intervention: Drug: Imatinib

Indicates status has not been verified in more than two years